A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo

被引:112
作者
Ehrhardt, A [1 ]
Kay, MA [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat & Genet, Stanford, CA 94305 USA
关键词
D O I
10.1182/blood.V99.11.3923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have developed a new helper-dependent (HD) adenoviral vector FTC that contains 3 cis-acting sequences as stuffer DNA: a human fragment of alphoid repeat DNA, matrix-attachment regions (MARs), and the hepatocyte control region enhancer. To determine the most robust human coagulation factor IX (hFIX) expression cassette in an adenovirus, we first tested different hFIX expression sequences with or without flanking MARs in first-generation adenoviral vectors. After Intravenous infusion of the vector, serum levels of up to 100 000 ng/mL hFIX (normal level, 5000 ng/mL) were obtained at nontoxic doses. In order to make a direct comparison, a first-generation and a gene-deleted vector with identical hFIX expression cassettes were constructed. Both first-generation and HD adenovirus-treated animals demonstrated a threshold effect in a dose-response study. With the administration of 2 x 10(9) transducing particles of either vector, supraphysiological serum levels of hFIX were obtained, with the highest expression (41 000 ng/mL) occurring during the first 2 months after injection. The serum factor IX concentrations, while remaining in the therapeutic range, slowly declined by 95% over a period of 1 year. At this dose, interleukin-6 and tumor necrosis factor-alpha serum concentrations were elevated in animals that received the first-generation but not the HD vector. This study compares the properties of a gene-deleted and first-generation adenovirus with equivalent expression cassettes and suggests that the cis-DNA elements contained in the vector and expression cassette have important effects on gene expression in vivo. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3923 / 3930
页数:8
相关论文
共 48 条
[1]   Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector [J].
Balagué, C ;
Zhou, JM ;
Dai, YF ;
Alemany, R ;
Josephs, SF ;
Andreason, G ;
Hariharan, M ;
Sethi, E ;
Prokopenko, E ;
Jan, HY ;
Lou, YC ;
Hubert-Leslie, D ;
Ruiz, L ;
Zhang, WW .
BLOOD, 2000, 95 (03) :820-828
[2]  
BARR D, 1995, GENE THER, V2, P151
[3]   Adenovirus vectors for gene delivery [J].
Benihoud, K ;
Yeh, P ;
Perricaudet, M .
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (05) :440-447
[4]   ELEMENTS REGULATING SOMATIC HYPERMUTATION OF AN IMMUNOGLOBULIN-KAPPA GENE - CRITICAL ROLE FOR THE INTRON ENHANCER MATRIX ATTACHMENT REGION [J].
BETZ, AG ;
MILSTEIN, C ;
GONZALEZFERNANDEZ, A ;
PANNELL, R ;
LARSON, T ;
NEUBERGER, MS .
CELL, 1994, 77 (02) :239-248
[5]   In vivo dose threshold effect of adenovirus-mediated Factor VIII cone therapy in hemophiliac mice [J].
Bristol, JA ;
Shirley, P ;
Idamakanti, N ;
Kaleko, M ;
Connelly, S .
MOLECULAR THERAPY, 2000, 2 (03) :223-232
[6]   Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector [J].
Dong, JY ;
Wang, DH ;
VanGinkel, FW ;
Pascual, DW ;
Frizzell, RA .
HUMAN GENE THERAPY, 1996, 7 (03) :319-331
[7]   ADENOVIRUS-MEDIATED TRANSFER OF THE CFTR GENE TO LUNG OF NONHUMAN-PRIMATES - BIOLOGICAL EFFICACY STUDY [J].
ENGELHARDT, JF ;
SIMON, RH ;
YANG, YP ;
ZEPEDA, M ;
WEBERPENDLETON, S ;
DORANZ, B ;
GROSSMAN, M ;
WILSON, JM .
HUMAN GENE THERAPY, 1993, 4 (06) :759-769
[8]   Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9 [J].
Fields, PA ;
Arruda, VR ;
Armstrong, E ;
Chu, K ;
Mingozzi, F ;
Hagstrom, JN ;
Herzog, RW ;
High, KA .
MOLECULAR THERAPY, 2001, 4 (03) :201-210
[9]   Factors influencing the development of an anti-factor IX (FIX) response following administration of adeno-associated virus-FIX [J].
Ge, Y ;
Powell, S ;
Van Roey, M ;
McArthur, JG .
BLOOD, 2001, 97 (12) :3733-3737
[10]   A MOUSE MODEL FOR INVESTIGATING THE MOLECULAR PATHOGENESIS OF ADENOVIRUS PNEUMONIA [J].
GINSBERG, HS ;
MOLDAWER, LL ;
SEHGAL, PB ;
REDINGTON, M ;
KILIAN, PL ;
CHANOCK, RM ;
PRINCE, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1651-1655